Laurus Labs shares climb 4% after Q2 profit zooms 126% YoY

The Quick Take
Laurus Labs shares rose 3.79% to Rs 2,329 after the pharmaceutical company reported strong Q2FY27 results. Revenue increased 33% year-on-year to Rs 2,206 crore, while net profit more than doubled to Rs 441 crore. Growth was supported by sustained momentum in its CDMO business and Affordable Medicines division, alongside improving margins and continued investments in manufacturing capabilities.
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to Economic Times.
Related
Business
Шестой ежегодный «Всемирный день коррекции неудачной трансплантации волос» 11 ноября: помощь пострадавшим от нелегальных операций и информирование о настораживающих признаках
Число нелегальных клиник по пересадке волос растет — хирургические вмешательства незаконно проводят лица без надлежащей квалификации, хотя такие операции…
Business
SPIE organic growth accelerates as North-West Europe delivers surprise rebound
Business
Citizens downgrades Reddit stock rating on user growth concerns
Business
